Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.
about
MAO-inhibitors in Parkinson's DiseaseNeuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stressCognitive Behaviour Therapy for Depression and Anxiety in Parkinson's DiseaseThe Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's DiseaseCulture, gender and health care stigma: Practitioners' response to facial masking experienced by people with Parkinson's disease.Neuroimaging in Parkinson disease: from research setting to clinical practice.Imbalance of glial-neuronal interaction in synapses: a possible mechanism of the pathophysiology of bipolar disorder.Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Neurologists' diagnostic accuracy of depression and cognitive problems in patients with parkinsonismClinical aspects of palliative care in advanced Parkinson's disease.Depression in Parkinson's disease -- a review.Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's diseaseNeurobiology of depression and anxiety in Parkinson's diseaseNeuropsychiatric non-motor aspects of Parkinson's disease.The effect of cognitive impairment on mental healthcare costs for individuals with severe psychiatric illness.Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's diseaseA matter of motion or an emotional matter? Management of depression in Parkinson's disease.Late-life depression: a neuropsychiatric approach.Rumination and behavioural factors in Parkinson's disease depressionThe patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PDBiomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry.The course of depressive symptoms in early Parkinson's disease.Distant delivery of a mindfulness-based intervention for people with Parkinson's disease: the study protocol of a randomised pilot trial.Ethical perspectives on relations between industry and neuropsychiatric medicine.Imaging dopamine transporters in Parkinson's disease.When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease.Anhedonia in Parkinson's disease: a systematic review of the literature.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Advances in non-dopaminergic treatments for Parkinson's diseaseAssociation between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis.Prodromal non-motor symptoms of Parkinson's disease.Implications of Circadian Rhythm in Dopamine and Mood Regulation.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Neuropsychiatric phenomena associated with movement disorders.Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson's disease.Depression in Parkinson's Disease: The Contribution from Animal Studies.Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.
P2860
Q24629770-2DCB2294-67AB-4ABC-8D62-D400F27E1004Q24678238-CC943E97-B52B-4992-A610-E2382D2998FCQ26781122-2A7D83A5-D7FC-4F1A-9BA2-02A03DA462FAQ28078546-5099BAE3-9B81-4047-BA38-2C9FC773E7E9Q30502799-D33032DE-2C4C-4FD5-9AE3-59391C728E0BQ30868628-75CBC5EB-B877-4572-940A-4EE93B335ABCQ33203078-AFCB8400-7CEF-4129-AD1F-760CF2CB47F4Q33260251-59175B7F-61EF-4618-8EB3-3679C92CDA63Q33731267-6236CB72-3FB0-48AD-B796-AE6DF1C4E5C2Q34306196-DFF20B8A-CF65-45D4-A1AF-3EDE5DDF8F33Q34457767-32679EEB-CA74-47E0-9504-3C693C10BDBFQ34478301-240BAF8B-6E1B-4B99-8846-258293AFFCB0Q34493954-42B51DA7-8C56-4C5F-B055-C429482305F3Q35028706-BB071312-1888-4A46-9972-7EE7FB2EFEEBQ35518017-C17C95F6-4936-4ECA-B453-2E2AEA7D9F99Q35617316-6CD5B482-055E-4241-A057-764CAB6F2301Q36227514-E9465E46-7CB8-4500-8FAC-694674821A82Q36307871-0F815A18-7724-43F4-96C5-4E24E6428323Q36390860-DBFC2204-C285-4509-9C6E-F1D4B694EDB9Q36698247-8417C44C-97D7-4D23-A66D-6B9A7B96B30CQ37129850-F98E5E6D-445C-401E-8A1F-C25626808CCDQ37358672-D4090733-3B40-4647-AAA0-58980E51C518Q37371215-80685E0C-F09B-4724-91B9-E9A7191DAD1CQ37457863-97965AED-611A-4CEA-9A71-601DA69C4D34Q37593613-2CDA05B4-4ABC-4A09-9A6C-C04E21653BE7Q37763210-4ED97CD5-5890-401C-B5F3-ABFD90944A9DQ37800096-1251A442-44E2-4379-B578-4EFB176EC843Q37874195-82BFB266-278A-4A47-AD92-820017DA8026Q37887678-D3712939-6BF7-4CC6-A42A-87CD08C89E3DQ38070888-7186EF22-F688-411D-B49F-B861FCB6AA44Q38218083-109C0D84-A7C6-4D4A-A151-2BE3189D2CB3Q38223905-3D20315F-F858-433C-899C-D156F608F673Q40247459-489A9262-3FE0-4CE7-B1AE-454CC1A12907Q41288556-3FC2B665-4566-4FFA-800A-D02C1D860E75Q42126269-94C3D2EA-22A4-49C8-9EDF-4CC1B4965F6FQ42373265-F6680A63-6C18-49AE-A318-683D82A64B09Q43142904-CA2F577B-7AC2-4234-A383-6F308F46F004Q44073890-73E5A41C-9208-44EB-B381-080C64727456Q44130207-BA816866-F980-4F12-AE48-8DEA3BAF5AB7Q44489208-837111BF-02A8-45E5-A284-961676253C48
P2860
Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@ast
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@en
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@nl
type
label
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@ast
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@en
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@nl
prefLabel
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@ast
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@en
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@nl
P2860
P356
P1433
P1476
Beyond the iron mask: towards ...... ated with Parkinson's disease.
@en
P2093
David J Burn
P2860
P304
P356
10.1002/MDS.10114
P407
P577
2002-05-01T00:00:00Z